BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19147091)

  • 41. Infections following peripheral blood progenitor cell transplantation.
    Mossad SB
    Am J Med; 1999 Nov; 107(5):536. PubMed ID: 10569320
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intraabdominal and hepatic infections in pediatric cancer patients].
    Ballauff A; Eggert A
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S101-9. PubMed ID: 16288356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients.
    Zuccotti G; Strasfeld L; Weinstock DM
    Expert Opin Pharmacother; 2005 Aug; 6(10):1669-79. PubMed ID: 16086653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Exciting progress in the field of infection medicine. Several breakthroughs are to be expected during the next decade].
    Andersson J; Iwarson S
    Lakartidningen; 1999 Dec; 96(48):5371-3. PubMed ID: 10612988
    [No Abstract]   [Full Text] [Related]  

  • 45. Infections following hematopoietic stem cell transplantation.
    Leather HL; Wingard JR
    Infect Dis Clin North Am; 2001 Jun; 15(2):483-520. PubMed ID: 11447707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccination of SCT recipients.
    Ljungman P; Small TN;
    Bone Marrow Transplant; 2011 Apr; 46(4):621. PubMed ID: 21102502
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravenous ascorbic acid: protocol for its application and use.
    Riordan HD; Hunninghake RB; Riordan NH; Jackson JJ; Meng X; Taylor P; Casciari JJ; González MJ; Miranda-Massari JR; Mora EM; Rosario N; Rivera A
    P R Health Sci J; 2003 Sep; 22(3):287-90. PubMed ID: 14619456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
    Rieger CT; Rieger H; Kolb HJ; Peterson L; Huppmann S; Fiegl M; Ostermann H
    Transpl Infect Dis; 2009 Jun; 11(3):220-6. PubMed ID: 19298239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Management of viral infections after allogeneic hematopoietic stem cell transplantation].
    Fukuda T
    Rinsho Ketsueki; 2011 Oct; 52(10):1413-22. PubMed ID: 21971216
    [No Abstract]   [Full Text] [Related]  

  • 50. Total parenteral nutrition-induced hyperglycemia in hematopoietic stem cell transplantation.
    Lenssen P
    J Am Diet Assoc; 2004 Sep; 104(9):1349-51. PubMed ID: 15354148
    [No Abstract]   [Full Text] [Related]  

  • 51. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
    Plantinga TS; van der Velden WJ; Ferwerda B; van Spriel AB; Adema G; Feuth T; Donnelly JP; Brown GD; Kullberg BJ; Blijlevens NM; Netea MG
    Clin Infect Dis; 2009 Sep; 49(5):724-32. PubMed ID: 19614557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Viral infection in renal transplant recipients.
    Cukuranovic J; Ugrenovic S; Jovanovic I; Visnjic M; Stefanovic V
    ScientificWorldJournal; 2012; 2012():820621. PubMed ID: 22654630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new step toward individualized antifungal prevention in hematopoietic stem cell transplantation.
    Bochud PY; Calandra T
    Clin Infect Dis; 2009 Sep; 49(5):733-5. PubMed ID: 19614558
    [No Abstract]   [Full Text] [Related]  

  • 54. Should quinolones be used in the treatment of bacterial infections in neutropenic patients?
    Piddock LJ; Dalhoff A
    J Antimicrob Chemother; 1993 Nov; 32(5):771-4. PubMed ID: 8125842
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pitfalls in management of infectious complications after hematopoietic cell transplantation].
    Mori S
    Rinsho Ketsueki; 2012 Oct; 53(10):1745-52. PubMed ID: 23037747
    [No Abstract]   [Full Text] [Related]  

  • 56. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble ophthalmic drug inserts with antibacterial and antiviral preparations.
    Maichuk IF
    Rev Int Trach Pathol Ocul Trop Subtrop; 1979; 56(1):55-64. PubMed ID: 472537
    [No Abstract]   [Full Text] [Related]  

  • 58. Ready-to-use T cells for infection after stem-cell transplant.
    Gilbert JA
    Lancet Oncol; 2017 Sep; 18(9):e519. PubMed ID: 28826590
    [No Abstract]   [Full Text] [Related]  

  • 59. Management of pediatric postrenal transplantation infections.
    Dharnidharka VR; Harmon WE
    Semin Nephrol; 2001 Sep; 21(5):521-31. PubMed ID: 11559893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 'Kennel cough' in a patient following allogeneic hematopoietic stem cell transplant.
    Goldberg JD; Kamboj M; Ford R; Kiehn TE; Gilhuley K; Perales MA
    Bone Marrow Transplant; 2009 Sep; 44(6):381-2. PubMed ID: 19234511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.